Following the first observation of frequent miR-17-92 over-expression in B-cell lymphomas [20], it has been experimentally demonstrated that its over-expression can indeed accelerate development of B-cell lymphoma initiated by Myc deregulation [21], [22]. Here, MYC is linked to B-cell non-Hodgkin lymphoma.